Organism name | Artemisia annua |
---|---|
Genus | Artemisia |
Family | Asteraceae |
Kingdom | Plantae |
Linked NCBI taxonomy name | Artemisia annua |
---|---|
Linked NCBI taxonomy ID | 35608 |
Linked level | species |
Family in NCBI taxonomy | Asteraceae |
---|---|
ID | 4210 |
Kingdom (Superkingdom) in NCBI taxonomy | Viridiplantae |
---|---|
ID | 33090 |
Plant class | asterids |
---|---|
ID | 71274 |
KNApSAcK ID | name | ChEMBL link | CTD link |
# of proteins in
ChEMBL interaction / related OMIM / related KEGG DISEASE |
# of genes in
CTD interaction / related diseases |
KCF-S
cluster |
phytochemical
cluster |
figure |
---|---|---|---|---|---|---|---|---|
C00003938
![]() |
Arcapillin
|
No. 3 | No. 15 |
![]() |
||||
C00004603
![]() |
Penduletin
/ 5,4'-Dihydroxy-3,6,7-trimethoxyflavone / 5-Hydroxy-2-(4-hydroxyphenyl)-3,6,7-trimethoxy-4H-1-benzopyran-4-one |
CHEMBL165509
|
3 / 3 / 0 | No. 3 | No. 15 |
![]() |
||
C00004729
![]() |
Gossypetin 3,4'-dimethyl ether
|
No. 3 | No. 15 |
![]() |
||||
C00004606
![]() |
Mikanin
/ 3,5-Dihydroxy-4',6,7-trimethoxyflavone / 3,5-Dihydroxy-6,7-dimethoxy-2-(4-methoxyphenyl)-4H-1-benzopyran-4-one |
CHEMBL554063
|
No. 3 | No. 15 |
![]() |
|||
C00004636
![]() |
Tamarixetin
/ 4'-O-Methylquercetin / 3,3',5,7-Tetrahydroxy-4'-methoxyflavone / 3,5,7-Trihydroxy-2-(3-hydroxy-4-methoxyphenyl)-4H-1-benzopyran-4-one |
CHEMBL226034
|
5 / 6 / 5 | No. 3 | No. 15 |
![]() |
||
C00004646
![]() |
Pachypodol
/ Quercetin 3,3',7-trimethyl ether / 5,4'-Dihydroxy-3,7,3'-trimethoxyflavone / 5-Hydroxy-2-(4-hydroxy-3-methoxyphenyl)-3,7-dimethoxy-4H-1-benzopyran-4-one |
CHEMBL165180
|
C008751
|
1 / 2 / 0 | No. 3 | No. 15 |
![]() |
|
C00004683
![]() |
Quercetagetin 4'-methyl ether
|
No. 3 | No. 15 |
![]() |
||||
C00004687
![]() |
Quercetagetin 3,4'-dimethyl ether
/ 5,6,7,3'-Tetrahydroxy-3,4'-dimethoxyflavone / 5,6,7-Trihydroxy-2-(3-hydroxy-4-methoxyphenyl)-3-methoxy-4H-1-benzopyran-4-one |
No. 3 | No. 15 |
![]() |
||||
C00004692
![]() |
Chrysosplenol D
/ Quercetagetin 3,6,7-Trimethyl ether / 5,3',4'-Trihydroxy-3,6,7-trimethoxyflavone / 2-(3,4-dihydroxyphenyl)-5-hydroxy-3,6,7-trimethoxy-4H-1-benzopyran-4-one |
CHEMBL491366
|
1 / 0 / 0 | No. 3 | No. 15 |
![]() |
||
C00004698
![]() |
Eupatin
|
CHEMBL77588
|
15 / 7 / 2 | No. 3 | No. 15 |
![]() |
||
C00004653
![]() |
Retusine
/ Retusin(Ariocarpus) / Quercetin 3,7,3',4'-tetramethyl ether / 5-Hydroxy-3,7,3',4'-tetramethoxyflavone / 2-(3,4-Dimethoxyphenyl)-5-hydroxy-3,7-dimethoxy-4H-1-benzopyran-4-one |
CHEMBL77966
|
3 / 3 / 0 | No. 8 | No. 15 |
![]() |
||
C00004705
![]() |
Casticin
/ Vitexicarpin / Quercetagetin 3,6,7,4'-tetramethyl ether / 3,6,7,4'-Tetra-O-methyl-5,3'-dihydroxyflavone / 5-Hydroxy-2-(3-hydroxy-4-methoxyphenyl)-3,6,7-trimethoxy-4H-1-benzopyran-4-one |
CHEMBL452767
|
C054133
|
No. 8 | No. 15 |
![]() |
||
C00004712
![]() |
Artemetin
/ 3,6,7,3',4'-Pentamethylquercetagetin / Quercetagetin 3,6,7,3',4'-pentamethyl ether / 2-(3,4-Dimethoxyphenyl)-5-hydroxy-3,6,7-trimethoxy-4H-1-benzopyran-4-one |
CHEMBL225700
|
C054132
|
0 / 5 | No. 8 | No. 15 |
![]() |
|
C00004709
![]() |
Quercetagetin 6,7,3',4'-tetramethyl ether
/ 2-(3,4-Dimethoxyphenyl)-3,5-dihydroxy-6,7-dimethoxy-4H-1-benzopyran-4-one |
No. 8 | No. 15 |
![]() |
||||
C00004704
![]() |
Polycladin
/ Chrysosplenetin / Quercetagetin 3,6,7,3'-tetramethyl ether / 5,4'-Dihydroxy-3,6,7,3'-tetramethoxyflavone / 5-Hydroxy-2-(4-hydroxy-3-methoxyphenyl)-3,6,7-trimethoxy-4H-1-benzopyran-4-one |
CHEMBL33256
|
C072749
|
No. 8 | No. 15 |
![]() |
||
C00030958
![]() |
Pentacosane
|
No. 115 |
![]() |
|||||
C00032307
![]() |
Tetracosane
/ n-Tetracosane |
No. 115 |
![]() |
|||||
C00021720
![]() |
beta-Cedrene
/ (+)-beta-Cedrene |
No. 149 | No. 38 |
![]() |
||||
C00003186
![]() |
beta-Selinene
|
C087920
|
No. 151 | No. 38 |
![]() |
|||
C00029350
![]() |
Z-beta-Farnesene
/ (Z)-beta-Farnesene / beta-cis-Farnesene / cis-beta-Farnesene |
No. 404 | No. 38 |
![]() |
||||
C00000829
![]() |
trans-Pinocarveol
|
No. 476 | No. 35 |
![]() |
||||
C00000805
![]() |
alpha-Pinene
|
CHEMBL442565
|
C005451
|
3 / 3 / 2 | 0 / 1 | No. 476 | No. 35 |
![]() |
C00029913
![]() |
Caryophylladienol II
|
No. 478 | No. 38 |
![]() |
||||
C00029912
![]() |
Caryophylladienol I
|
No. 478 | No. 38 |
![]() |
||||
C00003110
![]() |
Caryophyllene
/ (E)-Caryophyllene / beta-Caryophyllene / (-)-(E)-Caryophyllene / (E)-beta-Caryophyllene |
CHEMBL445740
CHEMBL448700 |
2 / 3 / 7 | No. 478 | No. 38 |
![]() |
||
C00029679
![]() |
alpha-Bisabolol
|
CHEMBL519167
CHEMBL491186 CHEMBL477832 CHEMBL1096927 CHEMBL1171719 CHEMBL1561544 CHEMBL2104360 |
C004497
|
8 / 4 / 13 | No. 541 | No. 38 |
![]() |
|
C00012425
![]() |
Bicyclogermacren
/ Bicyclogermacrene / (+)-Bicyclogermacrene |
CHEMBL509566
|
No. 699 | No. 38 |
![]() |
|||
C00030470
![]() |
Heneicosane
|
No. 732 |
![]() |
|||||
C00032409
![]() |
Tricosane
|
No. 732 |
![]() |
|||||
C00030165
![]() |
Eicosane
|
C050821
|
No. 732 |
![]() |
||||
C00030879
![]() |
Octadecane
|
C022883
|
No. 732 |
![]() |
||||
C00034408
![]() |
Amorpha-4,11-diene
/ (-)-Amorpha-4,11-diene |
No. 834 | No. 38 |
![]() |
||||
C00034419
![]() |
Artemisinic aldehyde
|
No. 834 | No. 38 |
![]() |
||||
C00044095
![]() |
Artemisinic acid methyl ester
|
No. 834 | No. 38 |
![]() |
||||
C00017521
![]() |
Qing Hau acid
/ Artemisic acid / Arteannuic acid / Artemisinic acid / Artemisininic acid |
CHEMBL457385
|
C047721
|
9 / 1 | No. 834 | No. 38 |
![]() |
|
C00032374
![]() |
Artemisinic alcohol
/ trans-Arteannuic alcohol |
No. 834 | No. 38 |
![]() |
||||
C00000155
![]() |
Thymol
|
CHEMBL29411
|
D013943
|
9 / 17 / 14 | 12 / 0 | No. 969 | No. 35 |
![]() |
C00000156
![]() |
Carvacrol
|
CHEMBL281202
|
C073316
|
10 / 6 / 1 | 4 / 2 | No. 969 | No. 35 |
![]() |
C00029674
![]() |
alpha-Terpineol
|
CHEMBL447597
CHEMBL449810 |
C016775
|
3 / 16 / 11 | No. 983 | No. 35 |
![]() |
|
C00011067
![]() |
Tricyclene
/ Teresantanane |
No. 1225 |
![]() |
|||||
C00000831
![]() |
(+)-trans-Sabinol
|
C052984
|
No. 1343 | No. 35 |
![]() |
|||
C00029974
![]() |
cis-Sabinol
|
No. 1343 | No. 35 |
![]() |
||||
C00007636
![]() |
delta-Cadinene
|
CHEMBL445759
|
No. 1524 | No. 39 |
![]() |
|||
C00029335
![]() |
beta-Ocimene
/ E-beta-Ocimene / (E)-beta-Ocimene |
C443996
|
No. 1698 | No. 34 |
![]() |
|||
C00029351
![]() |
Z-beta-Ocimene
/ cis-beta-Ocimene / (Z)-beta-Ocimene |
No. 1698 | No. 34 |
![]() |
||||
C00000356
![]() |
cis-3-Hexen-1-ol
|
C051918
|
0 / 1 | No. 1746 |
![]() |
|||
C00000619
![]() |
Eugenol
|
CHEMBL42710
|
D005054
|
103 / 45 / 36 | 152 / 28 | No. 1852 | No. 6 |
![]() |
C00003051
![]() |
alpha-Phellandrene
|
CHEMBL455041
|
C005403
|
No. 1898 | No. 35 |
![]() |
||
C00030481
![]() |
Hexyl 3-methyl butyrate
|
No. 2098 |
![]() |
|||||
C00029347
![]() |
(Z)-3-Hexenyl isovalerate
|
No. 2098 |
![]() |
|||||
C00003040
![]() |
p-Cymene
|
CHEMBL442915
|
C007210
|
No. 2172 | No. 35 |
![]() |
||
C00029544
![]() |
4-Terpineol
/ Terpin-4-ol / Terpineol-4 / Terpinen-4-ol |
CHEMBL507795
|
C034019
|
1 / 3 / 0 | No. 2215 |
![]() |
||
C00003032
![]() |
Chrysanthenone
|
No. 2232 | No. 35 |
![]() |
||||
C00000853
![]() |
Myrcene
|
CHEMBL455491
|
C008574
|
3 / 3 / 3 | No. 2285 | No. 34 |
![]() |
|
C00017522
![]() |
6,7-Dehydroartemisinic acid
|
No. 2317 | No. 38 |
![]() |
||||
C00003061
![]() |
gamma-Terpinene
/ 1-Methyl-4-(1-methylethyl)-1,4-cyclohexadiene |
CHEMBL449693
|
C018669
|
No. 2468 | No. 35 |
![]() |
||
C00003060
![]() |
alpha-Terpinene
|
No. 2468 | No. 35 |
![]() |
||||
C00011720
![]() |
Germacrene D
/ (-)-Germacrene D |
CHEMBL105432
CHEMBL1836650 |
No. 2639 | No. 38 |
![]() |
|||
C00011045
![]() |
delta-3-Carene
/ (-)-Carene(-)-3-Carene |
CHEMBL506854
|
No. 2690 | No. 35 |
![]() |
|||
C00029334
![]() |
(E)-Anethol
/ trans-Anethol / trans-1-(4-Methoxyphenyl)-1-propene |
CHEMBL452630
CHEMBL1468832 |
6 / 21 / 49 | No. 2748 | No. 6 |
![]() |
||
C00017523
![]() |
Arteannuin B
/ Qing Hau Sau II |
CHEMBL515516
CHEMBL2002073 |
C006634
|
9 / 8 / 5 | 0 / 1 | No. 2829 |
![]() |
|
C00017524
![]() |
Arteannuin C
/ Artemisinin C |
CHEMBL515516
CHEMBL2002073 |
9 / 8 / 5 | No. 2829 |
![]() |
|||
C00044150
![]() |
Dihydroarteannuin B
|
No. 2829 |
![]() |
|||||
C00010368
![]() |
Santolina alcohol
/ (S)-Santolina alcohol |
No. 2839 |
![]() |
|||||
C00010827
![]() |
Dehydro-1,8-cineole
|
No. 2943 |
![]() |
|||||
C00029353
![]() |
(Z)-Jasmone
/ cis-Jasmone |
C086299
|
No. 3251 |
![]() |
||||
C00029972
![]() |
cis-para-Mentha-2,8-dien-1-ol
|
CHEMBL504494
CHEMBL451087 |
No. 3348 |
![]() |
||||
C00029916
![]() |
Cedr-8(15)-en-9-alpha-ol acetate
|
No. 3453 |
![]() |
|||||
C00029423
![]() |
1-Octen-3-ol
|
C038844
|
0 / 1 | No. 3536 |
![]() |
|||
C00030880
![]() |
Octanal
/ n-Octanal |
CHEMBL18407
|
C031639
|
2 / 0 | No. 3593 |
![]() |
||
C00000358
![]() |
n-Hexanol
|
CHEMBL14085
|
C036260
|
3 / 6 / 3 | No. 3722 |
![]() |
||
C00000861
![]() |
Terpinolene
|
CHEMBL454697
|
C027009
|
1 / 0 | No. 3725 |
![]() |
||
C00003039
![]() |
Cuminaldehyde
/ Cuminyl aldehyde / 4-Isopropyl benzaldehyde |
CHEMBL161577
|
C007165
|
2 / 4 / 2 | No. 3751 | No. 35 |
![]() |
|
C00000821
![]() |
(+)-trans-Sabinene hydrate
|
No. 3782 | No. 35 |
![]() |
||||
C00012011
![]() |
delta-Elemene
|
No. 4001 |
![]() |
|||||
C00037033
![]() |
Deoxyarteannuin B
/ Deoxyisoartemisinin C |
No. 4141 |
![]() |
|||||
C00037054
![]() |
Dihydrodeoxyarteannuin B
|
No. 4141 |
![]() |
|||||
C00007268
![]() |
Farnesyl diphosphate
/ trans,trans-Farnesyl diphosphate |
CHEMBL69330
CHEMBL1160056 CHEMBL1160060 |
5 / 0 / 0 | No. 4178 | No. 38 |
![]() |
||
C00020376
![]() |
beta-Guaiene
|
C019408
|
No. 4203 |
![]() |
||||
C00003359
![]() |
quinghaosu
/ artemisinin / Quing hau sau |
CHEMBL6978
CHEMBL77 CHEMBL9903 CHEMBL269671 CHEMBL21926 CHEMBL34365 CHEMBL76666 CHEMBL101275 CHEMBL318507 CHEMBL345083 CHEMBL142061 CHEMBL349902 CHEMBL567597 CHEMBL1358398 CHEMBL1401626 CHEMBL1523872 CHEMBL1594115 CHEMBL2111908 CHEMBL2133885 |
C031327
|
106 / 64 / 56 | 15 / 5 | No. 4748 | No. 38 |
![]() |
C00020196
![]() |
Artemisitene
/ Dehydroqinghaosu |
CHEMBL315722
CHEMBL102244 CHEMBL155793 CHEMBL526138 CHEMBL2002513 |
C105118
|
No. 4748 | No. 38 |
![]() |
||
C00000136
![]() |
1,8-Cineole
|
CHEMBL485259
CHEMBL1397305 |
99 / 57 / 50 | No. 5413 | No. 35 |
![]() |
||
C00030220
![]() |
Ethyl 2-methyl butyrate
|
No. 6377 |
![]() |
|||||
C00029610
![]() |
9-Decen-1-ol
|
No. 7457 |
![]() |
|||||
C00030482
![]() |
Hexyl tiglate
|
No. 7850 |
![]() |
|||||
C00030130
![]() |
Dihydroartemisinic acid
/ (-)-Dihydroartemisinic acid |
No. 8620 |
![]() |
accession | description | class description | KNApSAcK metabolite in interactions |
# of diseases
(OMIM / KEGG) |
---|---|---|---|---|
P22310 | UDP-glucuronosyltransferase 1-4 | Enzyme | C00000155 C00000156 C00000619 C00029544 C00029674 | 3 / 0 |
P02545 | Prelamin-A/C | Unclassified protein | C00000136 C00000155 C00003359 C00029334 C00029674 | 11 / 10 |
P16473 | Thyrotropin receptor | Glycohormone receptor | C00000136 C00000358 C00000805 C00000853 C00029334 | 3 / 2 |
P08684 | Cytochrome P450 3A4 | Cytochrome P450 3A4 | C00000136 C00000619 C00003359 C00029334 C00029679 | 0 / 1 |
P28482 | Mitogen-activated protein kinase 1 | Erk | C00000136 C00000619 C00000805 C00003359 C00029679 | 0 / 0 |
O75496 | Geminin | Unclassified protein | C00000136 C00000619 C00003359 C00017523 C00017524 | 0 / 0 |
P35354 | Prostaglandin G/H synthase 2 | Oxidoreductase | C00000136 C00000155 C00000619 C00003359 C00029679 | 0 / 3 |
P23219 | Prostaglandin G/H synthase 1 | Oxidoreductase | C00000136 C00000156 C00000619 C00003359 | 0 / 0 |
P05177 | Cytochrome P450 1A2 | Cytochrome P450 1A2 | C00000136 C00000619 C00003359 C00004636 | 0 / 0 |
P83916 | Chromobox protein homolog 1 | Unclassified protein | C00000136 C00003359 C00017523 C00017524 | 0 / 0 |
P04150 | Glucocorticoid receptor | NR3C1 | C00000136 C00000619 C00000853 C00003359 | 0 / 1 |
P22309 | UDP-glucuronosyltransferase 1-1 | Enzyme | C00000155 C00000156 C00000619 C00029674 | 5 / 1 |
P08311 | Cathepsin G | S1A | C00000136 C00000619 C00003359 | 0 / 0 |
Q12809 | Potassium voltage-gated channel subfamily H member 2 | KCNH, Kv10-12.x (Ether-a-go-go) | C00000136 C00000619 C00003359 | 2 / 2 |
P08246 | Neutrophil elastase | S1A | C00000136 C00000619 C00003359 | 2 / 1 |
P33765 | Adenosine receptor A3 | Adenosine receptor | C00000136 C00000619 C00003359 | 0 / 0 |
Q16539 | Mitogen-activated protein kinase 14 | p38 | C00000136 C00000619 C00003359 | 0 / 0 |
P49146 | Neuropeptide Y receptor type 2 | Neuropeptide Y receptor | C00000136 C00000619 C00003359 | 0 / 0 |
P30542 | Adenosine receptor A1 | Adenosine receptor | C00000136 C00000619 C00003359 | 0 / 0 |
P29466 | Caspase-1 | C14 | C00000136 C00000619 C00003359 | 0 / 0 |
P17252 | Protein kinase C alpha type | Alpha | C00000136 C00000619 C00003359 | 0 / 0 |
P27361 | Mitogen-activated protein kinase 3 | Erk | C00000136 C00000619 C00003359 | 0 / 0 |
P14780 | Matrix metalloproteinase-9 | M10A | C00000136 C00000619 C00003359 | 2 / 2 |
P18089 | Alpha-2B adrenergic receptor | Adrenergic receptor | C00000136 C00000619 C00003359 | 0 / 0 |
P24557 | Thromboxane-A synthase | Cytochrome P450 5A1 | C00000136 C00000619 C00003359 | 1 / 1 |
P25100 | Alpha-1D adrenergic receptor | Adrenergic receptor | C00000136 C00000619 C00003359 | 0 / 0 |
P00918 | Carbonic anhydrase 2 | Lyase | C00000136 C00000619 C00003359 | 1 / 2 |
P07550 | Beta-2 adrenergic receptor | Adrenergic receptor | C00000136 C00000619 C00003359 | 0 / 1 |
P21397 | Amine oxidase [flavin-containing] A | Oxidoreductase | C00000136 C00000619 C00003359 | 1 / 1 |
Q99700 | Ataxin-2 | Unclassified protein | C00003359 C00017523 C00017524 | 1 / 1 |
P35367 | Histamine H1 receptor | Histamine receptor | C00000136 C00000619 C00003359 | 0 / 0 |
Q01959 | Sodium-dependent dopamine transporter | Dopamine | C00000136 C00000619 C00003359 | 1 / 0 |
P08912 | Muscarinic acetylcholine receptor M5 | Acetylcholine receptor | C00000136 C00000619 C00003359 | 0 / 0 |
P18825 | Alpha-2C adrenergic receptor | Adrenergic receptor | C00000136 C00000619 C00003359 | 0 / 0 |
P13945 | Beta-3 adrenergic receptor | Adrenergic receptor | C00000136 C00000619 C00003359 | 0 / 0 |
P23975 | Sodium-dependent noradrenaline transporter | Norepinephrine | C00000136 C00000619 C00003359 | 1 / 1 |
Q9UNQ0 | ATP-binding cassette sub-family G member 2 | ATP binding cassette | C00004603 C00004646 C00004653 | 2 / 0 |
P08588 | Beta-1 adrenergic receptor | Adrenergic receptor | C00000136 C00000619 C00003359 | 1 / 0 |
P25024 | C-X-C chemokine receptor type 1 | CXC chemokine receptor | C00000136 C00000619 C00003359 | 0 / 0 |
P06241 | Tyrosine-protein kinase Fyn | Src | C00000136 C00000619 C00003359 | 0 / 0 |
Q08209 | Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform | Ser_Thr | C00000136 C00000619 C00003359 | 0 / 0 |
P11712 | Cytochrome P450 2C9 | Cytochrome P450 2C9 | C00000136 C00000619 C00003359 | 0 / 1 |
Q16236 | Nuclear factor erythroid 2-related factor 2 | Unclassified protein | C00000358 C00017523 C00017524 | 0 / 0 |
P00533 | Epidermal growth factor receptor | TK tyrosine-protein kinase EGFR subfamily | C00000136 C00000619 C00003359 | 1 / 8 |
P14416 | D(2) dopamine receptor | Dopamine receptor | C00000136 C00000619 C00003359 | 2 / 0 |
P03372 | Estrogen receptor | NR3A1 | C00000136 C00000619 C00003359 | 1 / 1 |
P37288 | Vasopressin V1a receptor | Vasopressin and oxytocin receptor | C00000136 C00000619 C00003359 | 0 / 0 |
P41145 | Kappa-type opioid receptor | Opioid receptor | C00000136 C00000619 C00003359 | 0 / 0 |
Q9Y271 | Cysteinyl leukotriene receptor 1 | Leukotriene receptor | C00000136 C00000619 C00003359 | 0 / 0 |
P29274 | Adenosine receptor A2a | Adenosine receptor | C00000136 C00000619 C00003359 | 0 / 0 |
P25929 | Neuropeptide Y receptor type 1 | Neuropeptide Y receptor | C00000136 C00000619 C00003359 | 0 / 0 |
P50052 | Type-2 angiotensin II receptor | Angiotensin receptor | C00000136 C00000619 C00003359 | 1 / 1 |
P17948 | Vascular endothelial growth factor receptor 1 | Vegfr | C00000136 C00000619 C00003359 | 0 / 0 |
P41968 | Melanocortin receptor 3 | Melanocortin receptor | C00000136 C00000619 C00003359 | 1 / 0 |
P00352 | Retinal dehydrogenase 1 | Enzyme | C00000619 C00003359 C00029334 | 0 / 0 |
P11509 | Cytochrome P450 2A6 | Cytochrome P450 2A6 | C00000136 C00000619 C00003359 | 0 / 0 |
P19224 | UDP-glucuronosyltransferase 1-6 | Enzyme | C00000155 C00000156 C00000619 | 0 / 0 |
P06239 | Tyrosine-protein kinase Lck | Src | C00000136 C00000619 C00003359 | 0 / 1 |
P22303 | Acetylcholinesterase | Hydrolase | C00000136 C00000619 C00003359 | 1 / 0 |
P25025 | C-X-C chemokine receptor type 2 | CXC chemokine receptor | C00000136 C00000619 C00003359 | 0 / 0 |
O60656 | UDP-glucuronosyltransferase 1-9 | Enzyme | C00000155 C00000156 C00000619 | 0 / 0 |
P54855 | UDP-glucuronosyltransferase 2B15 | Enzyme | C00000155 C00000156 C00000619 | 0 / 0 |
P04035 | 3-hydroxy-3-methylglutaryl-coenzyme A reductase | Oxidoreductase | C00000136 C00000619 C00003359 | 0 / 0 |
P08913 | Alpha-2A adrenergic receptor | Adrenergic receptor | C00000136 C00000619 C00003359 | 0 / 0 |
P21917 | D(4) dopamine receptor | Dopamine receptor | C00000136 C00000619 C00003359 | 0 / 0 |
P30988 | Calcitonin receptor | Calcitonin receptor | C00000136 C00000619 C00003359 | 0 / 0 |
P35462 | D(3) dopamine receptor | Dopamine receptor | C00000136 C00000619 C00003359 | 1 / 0 |
P41143 | Delta-type opioid receptor | Opioid receptor | C00000136 C00000619 C00003359 | 0 / 0 |
Q92731 | Estrogen receptor beta | NR3A2 | C00000136 C00000619 C00003359 | 0 / 1 |
P41595 | 5-hydroxytryptamine receptor 2B | Serotonin receptor | C00000136 C00000619 C00003359 | 0 / 0 |
P10635 | Cytochrome P450 2D6 | Cytochrome P450 2D6 | C00000136 C00000619 C00003359 | 1 / 0 |
P25101 | Endothelin-1 receptor | Endothelin receptor | C00000136 C00000619 C00003359 | 0 / 0 |
P30411 | B2 bradykinin receptor | Bradykinin receptor | C00000136 C00000619 C00003359 | 0 / 0 |
P05181 | Cytochrome P450 2E1 | Cytochrome P450 2E1 | C00000136 C00000619 C00003359 | 0 / 0 |
P32245 | Melanocortin receptor 4 | Melanocortin receptor | C00000136 C00000619 C00003359 | 1 / 0 |
P32238 | Cholecystokinin receptor type A | Cholecystokinin receptor | C00000136 C00000619 C00003359 | 0 / 0 |
P21728 | D(1A) dopamine receptor | Dopamine receptor | C00000136 C00000619 C00003359 | 0 / 0 |
Q99720 | Sigma non-opioid intracellular receptor 1 | Membrane receptor | C00000136 C00000619 C00003359 | 1 / 0 |
O76074 | cGMP-specific 3',5'-cyclic phosphodiesterase | PDE_5A | C00000136 C00000619 C00003359 | 0 / 0 |
P33261 | Cytochrome P450 2C19 | Cytochrome P450 2C19 | C00000136 C00000619 C00003359 | 1 / 1 |
P08575 | Receptor-type tyrosine-protein phosphatase C | Enzyme | C00000136 C00000619 C00003359 | 2 / 1 |
P03956 | Interstitial collagenase | M10A | C00000136 C00000619 C00003359 | 0 / 1 |
P32241 | Vasoactive intestinal polypeptide receptor 1 | Vasoactive intestinal peptide receptor | C00000136 C00000619 C00003359 | 0 / 0 |
P33032 | Melanocortin receptor 5 | Melanocortin receptor | C00000136 C00000619 C00003359 | 0 / 0 |
Q96QE3 | ATPase family AAA domain-containing protein 5 | Unclassified protein | C00003359 C00017523 C00017524 | 0 / 0 |
P25105 | Platelet-activating factor receptor | PAF receptor | C00000136 C00000619 C00003359 | 0 / 0 |
P25103 | Substance-P receptor | Neurokinin receptor | C00000136 C00000619 C00003359 | 0 / 0 |
Q9Y4X1 | UDP-glucuronosyltransferase 2A1 | Enzyme | C00000155 C00000156 C00000619 | 0 / 0 |
P08172 | Muscarinic acetylcholine receptor M2 | Acetylcholine receptor | C00000136 C00000619 C00003359 | 2 / 0 |
P11229 | Muscarinic acetylcholine receptor M1 | Acetylcholine receptor | C00000136 C00000619 C00003359 | 0 / 0 |
P08173 | Muscarinic acetylcholine receptor M4 | Acetylcholine receptor | C00000136 C00000619 C00003359 | 0 / 0 |
P21554 | Cannabinoid receptor 1 | Cannabinoid receptor | C00000136 C00000619 C00003359 | 0 / 0 |
P31645 | Sodium-dependent serotonin transporter | Serotonin | C00000136 C00000619 C00003359 | 2 / 0 |
P04626 | Receptor tyrosine-protein kinase erbB-2 | TK tyrosine-protein kinase EGFR subfamily | C00000136 C00000619 C00003359 | 5 / 9 |
P20309 | Muscarinic acetylcholine receptor M3 | Acetylcholine receptor | C00000136 C00000619 C00003359 | 1 / 0 |
P35372 | Mu-type opioid receptor | Opioid receptor | C00000136 C00000619 C00003359 | 0 / 0 |
P21452 | Substance-K receptor | Neurokinin receptor | C00000136 C00000619 C00003359 | 0 / 0 |
P51679 | C-C chemokine receptor type 4 | CC chemokine receptor | C00000136 C00000619 C00003359 | 0 / 0 |
P51681 | C-C chemokine receptor type 5 | CC chemokine receptor | C00000136 C00000619 C00003359 | 3 / 0 |
P50406 | 5-hydroxytryptamine receptor 6 | Serotonin receptor | C00000136 C00000619 C00003359 | 0 / 0 |
P28335 | 5-hydroxytryptamine receptor 2C | Serotonin receptor | C00000136 C00000619 C00003359 | 0 / 0 |
P28223 | 5-hydroxytryptamine receptor 2A | Serotonin receptor | C00000136 C00000619 C00003359 | 0 / 0 |
P41597 | C-C chemokine receptor type 2 | CC chemokine receptor | C00000136 C00000619 C00003359 | 1 / 0 |
P25021 | Histamine H2 receptor | Histamine receptor | C00000136 C00000619 C00003359 | 0 / 0 |
P43220 | Glucagon-like peptide 1 receptor | Glucagon-like peptide receptor | C00017523 C00017524 | 0 / 0 |
P15121 | Aldose reductase | Enzyme | C00004603 C00004692 | 0 / 0 |
P84022 | Mothers against decapentaplegic homolog 3 | Unclassified protein | C00017523 C00017524 | 2 / 0 |
P08183 | Multidrug resistance protein 1 | drug | C00004603 C00004653 | 1 / 0 |
P10275 | Androgen receptor | NR3C4 | C00000136 C00000619 | 3 / 4 |
O75762 | Transient receptor potential cation channel subfamily A member 1 | Unclassified protein | C00000155 C00000156 | 1 / 0 |
Q9HAW8 | UDP-glucuronosyltransferase 1-10 | Enzyme | C00000156 C00000619 | 0 / 0 |
O75030 | Microphthalmia-associated transcription factor | Unclassified protein | C00017523 C00017524 | 4 / 4 |
O75874 | Isocitrate dehydrogenase [NADP] cytoplasmic | Enzyme | C00017523 C00017524 | 1 / 0 |
O00255 | Menin | Unclassified protein | C00003110 C00029679 | 2 / 5 |
Q9HAW9 | UDP-glucuronosyltransferase 1-8 | Enzyme | C00000156 C00000619 | 0 / 0 |
Q03164 | Histone-lysine N-methyltransferase 2A | Enzyme | C00003110 C00029679 | 1 / 2 |
P16050 | Arachidonate 15-lipoxygenase | Enzyme | C00029679 | 0 / 0 |
P15428 | 15-hydroxyprostaglandin dehydrogenase [NAD(+)] | Enzyme | C00003359 | 2 / 2 |
Q99714 | 3-hydroxyacyl-CoA dehydrogenase type-2 | Enzyme | C00003359 | 3 / 3 |
P55055 | Oxysterols receptor LXR-beta | NR1H3 | C00000136 | 0 / 0 |
Q13133 | Oxysterols receptor LXR-alpha | NR1H3 | C00000136 | 0 / 0 |
Q96RI1 | Bile acid receptor | NR1H4 | C00000853 | 0 / 0 |
Q16678 | Cytochrome P450 1B1 | Cytochrome P450 1B1 | C00004636 | 4 / 4 |
P14679 | Tyrosinase | Oxidoreductase | C00003039 | 4 / 2 |
O94782 | Ubiquitin carboxyl-terminal hydrolase 1 | Enzyme | C00029679 | 0 / 0 |
Q9HC16 | DNA dC->dU-editing enzyme APOBEC-3G | Enzyme | C00000619 | 0 / 0 |
P63092 | Guanine nucleotide-binding protein G(s) subunit alpha isoforms short | Other membrane protein | C00003359 | 7 / 3 |
P51449 | Nuclear receptor ROR-gamma | Nuclear hormone receptor subfamily 1 group F member 3 | C00000805 | 0 / 0 |
P40763 | Signal transducer and activator of transcription 3 | Transcription Factor | C00029679 | 1 / 2 |
O00519 | Fatty-acid amide hydrolase 1 | Enzyme | C00003039 | 0 / 0 |
P10145 | Interleukin-8 | Secreted protein | C00000619 | 0 / 0 |
Q9UNA4 | DNA polymerase iota | Enzyme | C00003359 | 0 / 0 |
P42858 | Huntingtin | Unclassified protein | C00003359 | 1 / 1 |
P10636 | Microtubule-associated protein tau | Unclassified protein | C00000136 | 4 / 3 |
Q16665 | Hypoxia-inducible factor 1-alpha | Transcription Factor | C00003359 | 0 / 0 |
P04792 | Heat shock protein beta-1 | Unclassified protein | C00004636 | 2 / 1 |
P04798 | Cytochrome P450 1A1 | Cytochrome P450 1A1 | C00004636 | 0 / 0 |
O95749 | Geranylgeranyl pyrophosphate synthase | Enzyme | C00007268 | 0 / 0 |
P10828 | Thyroid hormone receptor beta | NR1A2 | C00000358 | 3 / 1 |
P10253 | Lysosomal alpha-glucosidase | Hydrolase | C00003359 | 1 / 1 |
P09917 | Arachidonate 5-lipoxygenase | Oxidoreductase | C00004636 | 0 / 0 |
Q7Z2W7 | Transient receptor potential cation channel subfamily M member 8 | Unclassified protein | C00000136 | 0 / 0 |
O75795 | UDP-glucuronosyltransferase 2B17 | Enzyme | C00000619 | 1 / 0 |
P04637 | Cellular tumor antigen p53 | Transcription Factor | C00029334 | 7 / 37 |
B2RXH2 | Lysine-specific demethylase 4E | Enzyme | C00029334 | 0 / 0 |
P46063 | ATP-dependent DNA helicase Q1 | Enzyme | C00000136 | 0 / 0 |
P33527 | Multidrug resistance-associated protein 1 | drugs | C00004653 | 0 / 0 |
O75469 | Nuclear receptor subfamily 1 group I member 2 | NR1I2 | C00003359 | 0 / 0 |
P37268 | Squalene synthase | Enzyme | C00007268 | 0 / 0 |
Q13951 | Core-binding factor subunit beta | Unclassified protein | C00003359 | 0 / 1 |
Q01196 | Runt-related transcription factor 1 | Unclassified protein | C00003359 | 1 / 4 |
P49356 | Protein farnesyltransferase subunit beta | Enzyme | C00007268 | 0 / 0 |
P49354 | Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha | Enzyme | C00007268 | 0 / 0 |
P53609 | Geranylgeranyl transferase type-1 subunit beta | Enzyme | C00007268 | 0 / 0 |
Q13748 | Tubulin alpha-3C/D chain | Structural | C00004698 | 0 / 0 |
P68366 | Tubulin alpha-4A chain | Structural | C00004698 | 0 / 0 |
Q9H4B7 | Tubulin beta-1 chain | Structural | C00004698 | 1 / 0 |
P04350 | Tubulin beta-4A chain | Structural | C00004698 | 2 / 0 |
Q3ZCM7 | Tubulin beta-8 chain | Structural | C00004698 | 0 / 0 |
P07437 | Tubulin beta chain | Structural | C00004698 | 0 / 0 |
Q71U36 | Tubulin alpha-1A chain | Structural | C00004698 | 1 / 1 |
P68371 | Tubulin beta-4B chain | Structural | C00004698 | 0 / 0 |
Q13509 | Tubulin beta-3 chain | Structural | C00004698 | 2 / 1 |
Q13148 | TAR DNA-binding protein 43 | Unclassified protein | C00003359 | 1 / 1 |
P68363 | Tubulin alpha-1B chain | Unclassified protein | C00004698 | 0 / 0 |
Q13885 | Tubulin beta-2A chain | Structural | C00004698 | 0 / 0 |
Q6PEY2 | Tubulin alpha-3E chain | Unclassified protein | C00004698 | 0 / 0 |
Q9BQE3 | Tubulin alpha-1C chain | Unclassified protein | C00004698 | 0 / 0 |
Q9BUF5 | Tubulin beta-6 chain | Structural | C00004698 | 0 / 0 |
Q9BVA1 | Tubulin beta-2B chain | Structural | C00004698 | 1 / 0 |
gene | gene name | gene description | KNApSAcK metabolite in interactions |
---|---|---|---|
162514 | TRPV3, OLMS, VRL3 | transient receptor potential cation channel, subfamily V, member 3 |
C00000155
C00000156
C00000619
|
7366 | UGT2B15, HLUG4, UDPGT_2B8, UDPGT2B15, UDPGTH3, UGT2B8 | UDP glucuronosyltransferase 2 family, polypeptide B15 (EC:2.4.1.17) |
C00000156
C00000619
|
54576 | UGT1A8, UDPGT, UDPGT_1-8, UGT-1H, UGT1-08, UGT1.8, UGT1A8S, UGT1H | UDP glucuronosyltransferase 1 family, polypeptide A8 (EC:2.4.1.17) |
C00000155
C00000619
|
54577 | UGT1A7, UDPGT, UDPGT_1-7, UGT-1G, UGT1-07, UGT1.7, UGT1G | UDP glucuronosyltransferase 1 family, polypeptide A7 (EC:2.4.1.17) |
C00000155
C00000619
|
54575 | UGT1A10, UDPGT, UGT-1J, UGT1-10, UGT1.10, UGT1J | UDP glucuronosyltransferase 1 family, polypeptide A10 (EC:2.4.1.17) |
C00000155
C00000619
|
54658 | UGT1A1, BILIQTL1, GNT1, HUG-BR1, UDPGT, UDPGT_1-1, UGT1, UGT1A | UDP glucuronosyltransferase 1 family, polypeptide A1 (EC:2.4.1.17) |
C00000155
C00000619
|
596 | BCL2, Bcl-2, PPP1R50 | B-cell CLL/lymphoma 2 |
C00000155
C00000619
|
54600 | UGT1A9, HLUGP4, LUGP4, UDPGT, UDPGT_1-9, UGT-1I, UGT1-09, UGT1-9, UGT1.9, UGT1AI, UGT1I | UDP glucuronosyltransferase 1 family, polypeptide A9 (EC:2.4.1.17) |
C00000155
C00000619
|
2938 | GSTA1, GST2, GSTA1-1, GTH1 | glutathione S-transferase alpha 1 (EC:2.5.1.18) |
C00000619
C00003359
|
2950 | GSTP1, DFN7, FAEES3, GST3, GSTP, PI | glutathione S-transferase pi 1 (EC:2.5.1.18) |
C00000619
C00003359
|
1544 | CYP1A2, CP12, P3-450, P450(PA) | cytochrome P450, family 1, subfamily A, polypeptide 2 (EC:1.14.14.1) |
C00000619
C00003359
|
4790 | NFKB1, EBP-1, KBF1, NF-kB1, NF-kappa-B, NF-kappaB, NFKB-p105, NFKB-p50, NFkappaB, p105, p50 | nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 |
C00000619
C00003359
|
836 | CASP3, CPP32, CPP32B, SCA-1 | caspase 3, apoptosis-related cysteine peptidase (EC:3.4.22.56) |
C00000155
C00000156
|
231 | AKR1B1, ADR, ALDR1, ALR2, AR | aldo-keto reductase family 1, member B1 (aldose reductase) (EC:1.1.1.21) |
C00000619
C00030880
|
5970 | RELA, NFKB3, p65 | v-rel avian reticuloendotheliosis viral oncogene homolog A |
C00000619
C00003359
|
5327 | PLAT, T-PA, TPA | plasminogen activator, tissue (EC:3.4.21.68) |
C00000619
|
8856 | NR1I2, BXR, ONR1, PAR, PAR1, PAR2, PARq, PRR, PXR, SAR, SXR | nuclear receptor subfamily 1, group I, member 2 |
C00003359
|
221 | ALDH3B1, ALDH4, ALDH7 | aldehyde dehydrogenase 3 family, member B1 (EC:1.2.1.5) |
C00030880
|
1050 | CEBPA, C/EBP-alpha, CEBP | CCAAT/enhancer binding protein (C/EBP), alpha |
C00017521
|
1638 | DCT, TRP-2, TYRP2 | dopachrome tautomerase (EC:5.3.3.12) |
C00017521
|
3156 | HMGCR, LDLCQ3 | 3-hydroxy-3-methylglutaryl-CoA reductase (EC:1.1.1.34) |
C00017521
|
3815 | KIT, C-Kit, CD117, PBT, SCFR | v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog (EC:2.7.10.1) |
C00017521
|
4254 | KITLG, FPH2, KL-1, Kitl, MGF, SCF, SF, SHEP7 | KIT ligand |
C00017521
|
4282 | MIF, GIF, GLIF, MMIF | macrophage migration inhibitory factor (glycosylation-inhibiting factor) (EC:5.3.3.12 5.3.2.1) |
C00017521
|
4286 | MITF, CMM8, MI, WS2, WS2A, bHLHe32 | microphthalmia-associated transcription factor |
C00017521
|
7299 | TYR, ATN, CMM8, OCA1, OCA1A, OCAIA, SHEP3 | tyrosinase (EC:1.14.18.1) |
C00017521
|
7306 | TYRP1, CAS2, CATB, GP75, OCA3, TRP, TRP1, TYRP, b-PROTEIN | tyrosinase-related protein 1 (EC:1.14.18.-) |
C00017521
|
4792 | NFKBIA, IKBA, MAD-3, NFKBI | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha |
C00003359
|
8989 | TRPA1, ANKTM1, FEPS | transient receptor potential cation channel, subfamily A, member 1 |
C00000156
|
3551 | IKBKB, IKK-beta, IKK2, IKKB, NFKBIKB | inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta (EC:2.7.11.10) |
C00003359
|
1576 | CYP3A4, CP33, CP34, CYP3A, CYP3A3, CYPIIIA3, CYPIIIA4, HLP, NF-25, P450C3, P450PCN1 | cytochrome P450, family 3, subfamily A, polypeptide 4 (EC:1.14.13.67 1.14.13.97 1.14.13.32 1.14.13.157) |
C00003359
|
23460 | ABCA6, EST155051 | ATP-binding cassette, sub-family A (ABC1), member 6 |
C00000619
|
196 | AHR, bHLHe76 | aryl hydrocarbon receptor |
C00000619
|
57016 | AKR1B10, AKR1B11, AKR1B12, ALDRLn, ARL-1, ARL1, HIS, HSI | aldo-keto reductase family 1, member B10 (aldose reductase) (EC:1.1.1.2) |
C00000619
|
1645 | AKR1C1, 2-ALPHA-HSD, 20-ALPHA-HSD, C9, DD1, DD1/DD2, DDH, DDH1, H-37, HAKRC, HBAB, MBAB | aldo-keto reductase family 1, member C1 (EC:1.3.1.20 1.1.1.149 1.1.1.112) |
C00000619
|
8644 | AKR1C3, DD3, DDX, HA1753, HAKRB, HAKRe, HSD17B5, PGFS, hluPGFS | aldo-keto reductase family 1, member C3 (EC:1.3.1.20 1.1.1.188 1.1.1.239 1.1.1.64 1.1.1.112 1.1.1.357) |
C00000619
|
249 | ALPL, AP-TNAP, APTNAP, HOPS, TNAP, TNSALP | alkaline phosphatase, liver/bone/kidney (EC:3.1.3.1) |
C00000619
|
367 | AR, AIS, DHTR, HUMARA, HYSP1, KD, NR3C4, SBMA, SMAX1, TFM | androgen receptor |
C00000619
|
55114 | ARHGAP17, MST066, MST110, MSTP038, MSTP066, MSTP110, NADRIN, PP367, PP4534, RICH1, RICH1B, WBP15 | Rho GTPase activating protein 17 |
C00000619
|
10123 | ARL4C, ARL7, LAK | ADP-ribosylation factor-like 4C |
C00000619
|
567 | B2M | beta-2-microglobulin |
C00000619
|
1557 | CYP2C19, CPCJ, CYP2C, P450C2C, P450IIC19 | cytochrome P450, family 2, subfamily C, polypeptide 19 (EC:1.14.13.48 1.14.13.49 1.14.13.80) |
C00003359
|
9774 | BCLAF1, BTF, bK211L9.1 | BCL2-associated transcription factor 1 |
C00000619
|
654 | BMP6, VGR, VGR1 | bone morphogenetic protein 6 |
C00000619
|
699 | BUB1, BUB1A, BUB1L, hBUB1 | BUB1 mitotic checkpoint serine/threonine kinase (EC:2.7.11.1) |
C00000619
|
57102 | C12orf4 | chromosome 12 open reading frame 4 |
C00000619
|
10203 | CALCRL, CGRPR, CRLR | calcitonin receptor-like |
C00000619
|
847 | CAT | catalase (EC:1.11.1.6) |
C00000619
|
6357 | CCL13, CKb10, MCP-4, NCC-1, NCC1, SCYA13, SCYL1 | chemokine (C-C motif) ligand 13 |
C00000619
|
6363 | CCL19, CKb11, ELC, MIP-3b, MIP3B, SCYA19 | chemokine (C-C motif) ligand 19 |
C00000619
|
6347 | CCL2, GDCF-2, HC11, HSMCR30, MCAF, MCP-1, MCP1, SCYA2, SMC-CF | chemokine (C-C motif) ligand 2 |
C00000619
|
6348 | CCL3, G0S19-1, LD78ALPHA, MIP-1-alpha, MIP1A, SCYA3 | chemokine (C-C motif) ligand 3 |
C00000619
|
6349 | CCL3L1, 464.2, D17S1718, G0S19-2, LD78, LD78BETA, MIP1AP, SCYA3L, SCYA3L1 | chemokine (C-C motif) ligand 3-like 1 |
C00000619
|
6351 | CCL4, ACT2, AT744.1, G-26, HC21, LAG-1, LAG1, MIP-1-beta, MIP1B, MIP1B1, SCYA2, SCYA4 | chemokine (C-C motif) ligand 4 |
C00000619
|
729230 | CCR2, CC-CKR-2, CCR-2, CCR2A, CCR2B, CD192, CKR2, CKR2A, CKR2B, CMKBR2, MCP-1-R | chemokine (C-C motif) receptor 2 |
C00000619
|
1234 | CCR5, CC-CKR-5, CCCKR5, CCR-5, CD195, CKR-5, CKR5, CMKBR5, IDDM22 | chemokine (C-C motif) receptor 5 (gene/pseudogene) |
C00000619
|
1236 | CCR7, BLR2, CD197, CDw197, CMKBR7, EBI1 | chemokine (C-C motif) receptor 7 |
C00000619
|
948 | CD36, BDPLT10, CHDS7, FAT, GP3B, GP4, GPIV, PASIV, SCARB3 | CD36 molecule (thrombospondin receptor) |
C00000619
|
942 | CD86, B7-2, B7.2, B70, CD28LG2, LAB72 | CD86 molecule |
C00000619
|
1385 | CREB1, CREB | cAMP responsive element binding protein 1 |
C00000619
|
1390 | CREM, CREM-2, ICER, hCREM-2 | cAMP responsive element modulator |
C00000619
|
1514 | CTSL, CATL, CTSL1, MEP | cathepsin L (EC:3.4.22.15) |
C00000619
|
2919 | CXCL1, FSP, GRO1, GROa, MGSA, MGSA-a, NAP-3, SCYB1 | chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha) |
C00000619
|
7852 | CXCR4, CD184, D2S201E, FB22, HM89, HSY3RR, LAP3, LCR1, LESTR, NPY3R, NPYR, NPYRL, NPYY3R, WHIM | chemokine (C-X-C motif) receptor 4 |
C00000619
|
1543 | CYP1A1, AHH, AHRR, CP11, CYP1, P1-450, P450-C, P450DX | cytochrome P450, family 1, subfamily A, polypeptide 1 (EC:1.14.14.1) |
C00000619
|
1545 | CYP1B1, CP1B, CYPIB1, GLC3A, P4501B1 | cytochrome P450, family 1, subfamily B, polypeptide 1 (EC:1.14.14.1) |
C00000619
|
1593 | CYP27A1, CP27, CTX, CYP27 | cytochrome P450, family 27, subfamily A, polypeptide 1 (EC:1.14.13.15) |
C00000619
|
1559 | CYP2C9, CPC9, CYP2C, CYP2C10, CYPIIC9, P450IIC9 | cytochrome P450, family 2, subfamily C, polypeptide 9 (EC:1.14.13.48 1.14.13.49 1.14.13.80) |
C00000619
|
1565 | CYP2D6, CPD6, CYP2D, CYP2D7AP, CYP2D7BP, CYP2D7P2, CYP2D8P2, CYP2DL1, CYPIID6, P450-DB1, P450C2D, P450DB1 | cytochrome P450, family 2, subfamily D, polypeptide 6 (EC:1.14.14.1) |
C00000619
|
1571 | CYP2E1, CPE1, CYP2E, P450-J, P450C2E | cytochrome P450, family 2, subfamily E, polypeptide 1 (EC:1.14.13.n7) |
C00000619
|
1736 | DKC1, CBF5, DKC, DKCX, NAP57, NOLA4, XAP101 | dyskeratosis congenita 1, dyskerin |
C00000619
|
9787 | DLGAP5, DLG7, HURP | discs, large (Drosophila) homolog-associated protein 5 |
C00000619
|
1869 | E2F1, E2F-1, RBAP1, RBBP3, RBP3 | E2F transcription factor 1 |
C00000619
|
1870 | E2F2, E2F-2 | E2F transcription factor 2 |
C00000619
|
1871 | E2F3, E2F-3 | E2F transcription factor 3 |
C00000619
|
1874 | E2F4, E2F-4 | E2F transcription factor 4, p107/p130-binding |
C00000619
|
1875 | E2F5, E2F-5 | E2F transcription factor 5, p130-binding |
C00000619
|
1876 | E2F6, E2F-6 | E2F transcription factor 6 |
C00000619
|
1959 | EGR2, AT591, CMT1D, CMT4E, KROX20 | early growth response 2 |
C00000619
|
133418 | EMB | embigin |
C00000619
|
2099 | ESR1, ER, ESR, ESRA, ESTRR, Era, NR3A1 | estrogen receptor 1 |
C00000619
|
2100 | ESR2, ER-BETA, ESR-BETA, ESRB, ESTRB, Erb, NR3A2 | estrogen receptor 2 (ER beta) |
C00000619
|
2162 | F13A1, F13A | coagulation factor XIII, A1 polypeptide (EC:2.3.2.13) |
C00000619
|
26268 | FBXO9, FBX9, NY-REN-57, VCIA1, dJ341E18.2 | F-box protein 9 |
C00000619
|
2213 | FCGR2B, CD32, CD32B, FCG2, FCGR2, IGFR2 | Fc fragment of IgG, low affinity IIb, receptor (CD32) |
C00000619
|
2235 | FECH, EPP, FCE | ferrochelatase (EC:4.99.1.1) |
C00000619
|
2355 | FOSL2, FRA2 | FOS-like antigen 2 |
C00000619
|
2512 | FTL, NBIA3 | ferritin, light polypeptide |
C00000619
|
2539 | G6PD, G6PD1 | glucose-6-phosphate dehydrogenase (EC:1.1.1.49) |
C00000619
|
2729 | GCLC, GCL, GCS, GLCL, GLCLC | glutamate-cysteine ligase, catalytic subunit (EC:6.3.2.2) |
C00000619
|
2730 | GCLM, GLCLR | glutamate-cysteine ligase, modifier subunit (EC:6.3.2.2) |
C00000619
|
644076 | GLYCAM1 | glycosylation dependent cell adhesion molecule 1 (pseudogene) |
C00000619
|
2878 | GPX3, GPx-P, GSHPx-3, GSHPx-P | glutathione peroxidase 3 (plasma) (EC:1.11.1.9) |
C00000619
|
2932 | GSK3B | glycogen synthase kinase 3 beta (EC:2.7.11.1 2.7.11.26) |
C00000619
|
2936 | GSR | glutathione reductase (EC:1.8.1.7) |
C00000619
|
2944 | GSTM1, GST1, GSTM1-1, GSTM1a-1a, GSTM1b-1b, GTH4, GTM1, H-B, MU, MU-1 | glutathione S-transferase mu 1 (EC:2.5.1.18) |
C00000619
|
2994 | GYPB, CD235b, GPB, GPB.NY, GYPHe.NY, GpMiIII, HGpMiIII, HGpMiVI, HGpMiX, MNS, PAS-3, SS | glycophorin B (MNS blood group) |
C00000619
|
54497 | HEATR5B | HEAT repeat containing 5B |
C00000619
|
3091 | HIF1A, HIF-1A, HIF-1alpha, HIF1, HIF1-ALPHA, MOP1, PASD8, bHLHe78 | hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) |
C00000619
|
3106 | HLA-B, AS, HLAB, SPDA1 | major histocompatibility complex, class I, B |
C00000619
|
3162 | HMOX1, HMOX1D, HO-1, HSP32, bK286B10 | heme oxygenase (decycling) 1 (EC:1.14.99.3) |
C00000619
|
220988 | HNRNPA3, 2610510D13Rik, D10S102, FBRNP, HNRPA3 | heterogeneous nuclear ribonucleoprotein A3 |
C00000619
|
3381 | IBSP, BNSP, BSP, BSP-II, SP-II | integrin-binding sialoprotein |
C00000619
|
3422 | IDI1, IPP1, IPPI1 | isopentenyl-diphosphate delta isomerase 1 (EC:5.3.3.2) |
C00000619
|
3553 | IL1B, IL-1, IL1-BETA, IL1F2 | interleukin 1, beta |
C00000619
|
7850 | IL1R2, CD121b, CDw121b, IL-1R-2, IL-1RT-2, IL-1RT2, IL1R2c, IL1RB | interleukin 1 receptor, type II |
C00000619
|
3575 | IL7R, CD127, CDW127, IL-7R-alpha, IL7RA, ILRA | interleukin 7 receptor |
C00000619
|
3576 | IL8, CXCL8, GCP-1, GCP1, LECT, LUCT, LYNAP, MDNCF, MONAP, NAF, NAP-1, NAP1 | interleukin 8 |
C00000619
|
26034 | IPCEF1, PIP3-E, RP3-402L9.2 | interaction protein for cytohesin exchange factors 1 |
C00000619
|
3655 | ITGA6, CD49f, ITGA6B, VLA-6 | integrin, alpha 6 |
C00000619
|
3688 | ITGB1, CD29, FNRB, GPIIA, MDF2, MSK12, VLA-BETA, VLAB | integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12) |
C00000619
|
3741 | KCNA5, ATFB7, HCK1, HK2, HPCN1, KV1.5, PCN1 | potassium voltage-gated channel, shaker-related subfamily, member 5 |
C00000619
|
3759 | KCNJ2, ATFB9, HHBIRK1, HHIRK1, IRK1, KIR2.1, LQT7, SQT3 | potassium inwardly-rectifying channel, subfamily J, member 2 |
C00000619
|
9493 | KIF23, CHO1, KNSL5, MKLP-1, MKLP1 | kinesin family member 23 |
C00000619
|
23764 | MAFF, U-MAF, hMafF | v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog F |
C00000619
|
4097 | MAFG, hMAF | v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog G |
C00000619
|
7975 | MAFK, NFE2U, P18 | v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog K |
C00000619
|
28985 | MCTS1, MCT-1, MCT1 | malignant T cell amplified sequence 1 |
C00000619
|
4199 | ME1, HUMNDME, MES | malic enzyme 1, NADP(+)-dependent, cytosolic (EC:1.1.1.40) |
C00000619
|
4257 | MGST1, GST12, MGST, MGST-I | microsomal glutathione S-transferase 1 (EC:2.5.1.18) |
C00000619
|
51318 | MRPL35, L35mt, MRP-L35 | mitochondrial ribosomal protein L35 |
C00000619
|
58475 | MS4A7, 4SPAN2, CD20L4, CFFM4, MS4A8 | membrane-spanning 4-domains, subfamily A, member 7 |
C00000619
|
4501 | MT1X, MT-1l, MT1 | metallothionein 1X |
C00000619
|
4084 | MXD1, BHLHC58, MAD, MAD1 | MAX dimerization protein 1 |
C00000619
|
4602 | MYB, Cmyb, c-myb, c-myb_CDS, efg | v-myb avian myeloblastosis viral oncogene homolog |
C00000619
|
10135 | NAMPT, 1110035O14Rik, PBEF, PBEF1, VF, VISFATIN | nicotinamide phosphoribosyltransferase (EC:2.4.2.12) |
C00000619
|
4780 | NFE2L2, NRF2 | nuclear factor, erythroid 2-like 2 |
C00000619
|
1728 | NQO1, DHQU, DIA4, DTD, NMOR1, NMORI, QR1 | NAD(P)H dehydrogenase, quinone 1 (EC:1.6.5.2) |
C00000619
|
4927 | NUP88 | nucleoporin 88kDa |
C00000619
|
10606 | PAICS, ADE2, ADE2H1, AIRC, PAIS | phosphoribosylaminoimidazole carboxylase, phosphoribosylaminoimidazole succinocarboxamide synthetase (EC:6.3.2.6 4.1.1.21) |
C00000619
|
5142 | PDE4B, DPDE4, PDE4B5, PDEIVB | phosphodiesterase 4B, cAMP-specific (EC:3.1.4.17) |
C00000619
|
5226 | PGD, 6PGD | phosphogluconate dehydrogenase (EC:1.1.1.44) |
C00000619
|
8301 | PICALM, CALM, CLTH, LAP | phosphatidylinositol binding clathrin assembly protein |
C00000619
|
9970 | NR1I3, CAR, CAR1, MB67 | nuclear receptor subfamily 1, group I, member 3 |
C00003359
|
5366 | PMAIP1, APR, NOXA | phorbol-12-myristate-13-acetate-induced protein 1 |
C00000619
|
5468 | PPARG, CIMT1, GLM1, NR1C3, PPARG1, PPARG2, PPARgamma | peroxisome proliferator-activated receptor gamma |
C00000619
|
10935 | PRDX3, AOP-1, AOP1, HBC189, MER5, PRO1748, SP-22, prx-III | peroxiredoxin 3 (EC:1.11.1.15) |
C00000619
|
5733 | PTGER3, EP3, EP3-I, EP3-II, EP3-III, EP3-IV, EP3e, PGE2-R | prostaglandin E receptor 3 (subtype EP3) |
C00000619
|
22949 | PTGR1, LTB4DH, PGR1, ZADH3 | prostaglandin reductase 1 (EC:1.3.1.48 1.3.1.74) |
C00000619
|
5743 | PTGS2, COX-2, COX2, GRIPGHS, PGG/HS, PGHS-2, PHS-2, hCox-2 | prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) (EC:1.14.99.1) |
C00000619
|
5996 | RGS1, 1R20, BL34, IER1, IR20 | regulator of G-protein signaling 1 |
C00000619
|
6157 | RPL27A, L27A | ribosomal protein L27a |
C00000619
|
50484 | RRM2B, MTDPS8A, MTDPS8B, P53R2 | ribonucleotide reductase M2 B (TP53 inducible) (EC:1.17.4.1) |
C00000619
|
6303 | SAT1, DC21, KFSD, KFSDX, SAT, SSAT, SSAT-1 | spermidine/spermine N1-acetyltransferase 1 (EC:2.3.1.57) |
C00000619
|
6383 | SDC2, CD362, HSPG, HSPG1, SYND2 | syndecan 2 |
C00000619
|
55752 | SEPT11 | septin 11 |
C00000619
|
6504 | SLAMF1, CD150, CDw150, SLAM | signaling lymphocytic activation molecule family member 1 |
C00000619
|
117247 | SLC16A10, MCT10, PRO0813, TAT1 | solute carrier family 16 (aromatic amino acid transporter), member 10 |
C00000619
|
6515 | SLC2A3, GLUT3 | solute carrier family 2 (facilitated glucose transporter), member 3 |
C00000619
|
6647 | SOD1, ALS, ALS1, IPOA, SOD, hSod1, homodimer | superoxide dismutase 1, soluble (EC:1.15.1.1) |
C00000619
|
6648 | SOD2, IPOB, MNSOD, MVCD6 | superoxide dismutase 2, mitochondrial (EC:1.15.1.1) |
C00000619
|
6649 | SOD3, EC-SOD | superoxide dismutase 3, extracellular (EC:1.15.1.1) |
C00000619
|
140809 | SRXN1, C20orf139, Npn3, SRX, SRX1 | sulfiredoxin 1 (EC:1.8.98.2) |
C00000619
|
6772 | STAT1, CANDF7, ISGF-3, STAT91 | signal transducer and activator of transcription 1, 91kDa |
C00000619
|
6775 | STAT4, SLEB11 | signal transducer and activator of transcription 4 |
C00000619
|
6777 | STAT5B, STAT5 | signal transducer and activator of transcription 5B |
C00000619
|
7099 | TLR4, ARMD10, CD284, TLR-4, TOLL | toll-like receptor 4 |
C00000619
|
7124 | TNF, DIF, TNF-alpha, TNFA, TNFSF2 | tumor necrosis factor |
C00000619
|
7128 | TNFAIP3, A20, OTUD7C, TNFA1P2 | tumor necrosis factor, alpha-induced protein 3 (EC:3.4.19.12) |
C00000619
|
7130 | TNFAIP6, TSG-6, TSG6 | tumor necrosis factor, alpha-induced protein 6 |
C00000619
|
7157 | TP53, BCC7, LFS1, P53, TRP53 | tumor protein p53 |
C00000619
|
8626 | TP63, AIS, B(p51A), B(p51B), EEC3, KET, LMS, NBP, OFC8, RHS, SHFM4, TP53CP, TP53L, TP73L, p40, p51, p53CP, p63, p73H, p73L | tumor protein p63 |
C00000619
|
25828 | TXN2, MT-TRX, MTRX, TRX2 | thioredoxin 2 |
C00000619
|
7296 | TXNRD1, GRIM-12, TR, TR1, TRXR1, TXNR | thioredoxin reductase 1 (EC:1.8.1.9) |
C00000619
|
10587 | TXNRD2, SELZ, TR, TR-BETA, TR3, TRXR2 | thioredoxin reductase 2 (EC:1.8.1.9) |
C00000619
|
7358 | UGDH, GDH, UDP-GlcDH, UDPGDH, UGD | UDP-glucose 6-dehydrogenase (EC:1.1.1.22) |
C00000619
|
1555 | CYP2B6, CPB6, CYP2B, CYP2B7, CYP2B7P, CYPIIB6, EFVM, IIB1, P450 | cytochrome P450, family 2, subfamily B, polypeptide 6 (EC:1.14.14.1) |
C00003359
|
207 | AKT1, AKT, CWS6, PKB, PKB-ALPHA, PRKBA, RAC, RAC-ALPHA | v-akt murine thymoma viral oncogene homolog 1 (EC:2.7.11.1) |
C00000861
|
54578 | UGT1A6, GNT1, HLUGP, HLUGP1, UDPGT, UDPGT_1-6, UGT1, UGT1A6S, UGT1F | UDP glucuronosyltransferase 1 family, polypeptide A6 (EC:2.4.1.17) |
C00000619
|
1147 | CHUK, IKBKA, IKK-alpha, IKK1, IKKA, NFKBIKA, TCF16 | conserved helix-loop-helix ubiquitous kinase (EC:2.7.11.10) |
C00003359
|
8714 | ABCC3, ABC31, EST90757, MLP2, MOAT-D, MRP3, cMOAT2 | ATP-binding cassette, sub-family C (CFTR/MRP), member 3 |
C00003359
|
5243 | ABCB1, ABC20, CD243, CLCS, GP170, MDR1, P-GP, PGY1 | ATP-binding cassette, sub-family B (MDR/TAP), member 1 (EC:3.6.3.44) |
C00003359
|
7367 | UGT2B17, BMND12, UDPGT2B17 | UDP glucuronosyltransferase 2 family, polypeptide B17 (EC:2.4.1.17) |
C00000619
|
7421 | VDR, NR1I1 | vitamin D (1,25- dihydroxyvitamin D3) receptor |
C00000619
|
7709 | ZBTB17, MIZ-1, ZNF151, ZNF60, pHZ-67 | zinc finger and BTB domain containing 17 |
C00000619
|
9131 | AIFM1, AIF, CMTX4, COWCK, COXPD6, PDCD8 | apoptosis-inducing factor, mitochondrion-associated, 1 |
C00000155
|
581 | BAX, BCL2L4 | BCL2-associated X protein |
C00000155
|
841 | CASP8, ALPS2B, CAP4, Casp-8, FLICE, MACH, MCH5 | caspase 8, apoptosis-related cysteine peptidase (EC:3.4.22.61) |
C00000155
|
842 | CASP9, APAF-3, APAF3, ICE-LAP6, MCH6, PPP1R56 | caspase 9, apoptosis-related cysteine peptidase (EC:3.4.22.62) |
C00000155
|
OMIM | preferred title | UniProt |
---|---|---|
#300438 | 17-beta-hydroxysteroid dehydrogenase x deficiency |
Q99714
|
#100100 | Abdominal muscles, absence of, with urinary tract abnormality and cryptorchidism |
P20309
|
#219080 | Acth-independent macronodular adrenal hyperplasia; aimah |
P63092
|
#202300 | Adrenocortical carcinoma, hereditary; adcc |
P04637
|
#103470 | Albinism, ocular, with sensorineural deafness |
O75030
P14679 |
#203100 | Albinism, oculocutaneous, type ia; oca1a |
P14679
|
#606952 | Albinism, oculocutaneous, type ib; oca1b |
P14679
|
#103780 | Alcohol dependence |
P08172
P14416 P31645 |
#612069 | Amyotrophic lateral sclerosis 10, with or without frontotemporal dementia; als10 |
Q13148
|
#614373 | Amyotrophic lateral sclerosis 16, juvenile; als16 |
Q99720
|
#300068 | Androgen insensitivity syndrome; ais |
P10275
|
#312300 | Androgen insensitivity, partial; pais |
P10275
|
#614740 | Basal cell carcinoma, susceptibility to, 7; bcc7 |
P04637
|
#601816 | Bilirubin, serum level of, quantitative trait locus 1; biliqtl1 |
P22309
|
#614490 | Blood group, junior system; jr |
Q9UNQ0
|
#602025 | Body mass index quantitative trait locus 9; bmiq9 |
P41968
|
#612560 | Bone mineral density quantitative trait locus 12; bmnd12 |
O75795
|
#300615 | Brunner syndrome |
P21397
|
#115200 | Cardiomyopathy, dilated, 1a; cmd1a |
P02545
|
#212112 | Cardiomyopathy, dilated, with hypergonadotropic hypogonadism |
P02545
|
#605588 | Charcot-marie-tooth disease, axonal, type 2b1; cmt2b1 |
P02545
|
#606595 | Charcot-marie-tooth disease, axonal, type 2f; cmt2f |
P04792
|
#114500 | Colorectal cancer; crc |
P84022
|
#614039 | Cortical dysplasia, complex, with other brain malformations 1; cdcbm1 |
Q13509
|
#218800 | Crigler-najjar syndrome, type i |
P22309
P22310 |
#606785 | Crigler-najjar syndrome, type ii |
P22309
P22310 |
#162800 | Cyclic neutropenia |
P08246
|
#612522 | Diabetes mellitus, insulin-dependent, 22; iddm22 |
P51681
|
#119900 | Digital clubbing, isolated congenital |
P15428
|
#609535 | Drug metabolism, poor, cyp2c19-related |
P33261
|
#608902 | Drug metabolism, poor, cyp2d6-related |
P10635
|
#128101 | Dystonia 4, torsion, autosomal dominant; dyt4 |
P04350
|
#181350 | Emery-dreifuss muscular dystrophy 2, autosomal dominant; edmd2 |
P02545
|
#615040 | Episodic pain syndrome, familial, 1; feps1 |
O75762
|
#133239 | Esophageal cancer |
P04637
|
#615363 | Estrogen resistance; estrr |
P03372
|
#600638 | Fibrosis of extraocular muscles, congenital, 3a, with or without extraocular involvement; cfeom3a |
Q13509
|
#600274 | Frontotemporal dementia; ftd |
P10636
|
#613659 | Gastric cancer |
P04626
|
#137215 | Gastric cancer, hereditary diffuse; hdgc |
P04626
|
#231095 | Ghosal hematodiaphyseal dysplasia; ghdd |
P24557
|
#143500 | Gilbert syndrome |
P22309
P22310 |
#137750 | Glaucoma 1, open angle, a; glc1a |
Q16678
|
#231300 | Glaucoma 3, primary congenital, a; glc3a |
Q16678
|
#137760 | Glaucoma, primary open angle; poag |
Q16678
|
#137800 | Glioma susceptibility 1; glm1 |
O75874
P04626 |
#232300 | Glycogen storage disease ii |
P10253
|
#605130 | Hairy elbows, short stature, facial dysmorphism, and developmental delay |
Q03164
|
#610140 | Heart-hand syndrome, slovenian type |
P02545
|
#609423 | Human immunodeficiency virus type 1, susceptibility to |
P41597
P51681 |
#143100 | Huntington disease; hd |
P42858
|
#176670 | Hutchinson-gilford progeria syndrome; hgps |
P02545
|
#147060 | Hyper-ige recurrent infection syndrome, autosomal dominant |
P40763
|
#237900 | Hyperbilirubinemia, transient familial neonatal; hblrtfn |
P22309
|
#145000 | Hyperparathyroidism 1; hrpt1 |
O00255
|
#603373 | Hyperthyroidism, familial gestational |
P16473
|
#609152 | Hyperthyroidism, nonautoimmune |
P16473
|
#259100 | Hypertrophic osteoarthropathy, primary, autosomal recessive, 1; phoar1 |
P15428
|
#275200 | Hypothyroidism, congenital, nongoitrous, 1; chng1 |
P16473
|
#612244 | Inflammatory bowel disease 13; ibd13 |
P08183
|
#603932 | Intervertebral disc disease; idd |
P14780
|
#612438 | Leukodystrophy, hypomyelinating, 6; hld6 |
P04350
|
#151623 | Li-fraumeni syndrome 1; lfs1 |
P04637
|
#151660 | Lipodystrophy, familial partial, type 2; fpld2 |
P02545
|
#611603 | Lissencephaly 3; lis3 |
Q71U36
|
#613795 | Loeys-dietz syndrome, type 3; lds3 |
P84022
|
#613688 | Long qt syndrome 2; lqt2 |
Q12809
|
#211980 | Lung cancer |
P00533
P04626 P04637 |
#613112 | Macrothrombocytopenia, autosomal dominant, tubb1-related |
Q9H4B7
|
#608516 | Major depressive disorder; mdd |
P08172
|
#248370 | Mandibuloacral dysplasia with type a lipodystrophy; mada |
P02545
|
#174800 | Mccune-albright syndrome; mas |
P63092
|
#614456 | Melanoma, cutaneous malignant, susceptibility to, 8; cmm8 |
O75030
|
#300705 | Mental retardation, x-linked 17; mrx17 |
Q99714
|
%300852 | Mental retardation, x-linked 88; mrx88 |
P50052
|
#300220 | Mental retardation, x-linked, syndromic 10; mrxs10 |
Q99714
|
#613073 | Metaphyseal anadysplasia 2; mandp2 |
P14780
|
#131100 | Multiple endocrine neoplasia, type i; men1 |
O00255
|
#126200 | Multiple sclerosis, susceptibility to; ms |
P08575
|
#613205 | Muscular dystrophy, congenital, lmna-related |
P02545
|
#159001 | Muscular dystrophy, limb-girdle, type 1b; lgmd1b |
P02545
|
#159900 | Myoclonic dystonia |
P14416
|
#608634 | Neuronopathy, distal hereditary motor, type iib; hmn2b |
P04792
|
#202700 | Neutropenia, severe congenital, 1, autosomal dominant; scn1 |
P08246
|
#601665 | Obesity |
P32245
|
#164230 | Obsessive-compulsive disorder; ocd |
P31645
|
#604715 | Orthostatic intolerance |
P23975
|
#166350 | Osseous heteroplasia, progressive; poh |
P63092
|
#259730 | Osteopetrosis, autosomal recessive 3; optb3 |
P00918
|
#167000 | Ovarian cancer |
P04626
|
#260500 | Papilloma of choroid plexus; cpp |
P04637
|
#260540 | Parkinson-dementia syndrome |
P10636
|
#613135 | Parkinsonism-dystonia, infantile; pkdys |
Q01959
|
#604229 | Peters anomaly |
Q16678
|
#172700 | Pick disease of brain |
P10636
|
#102200 | Pituitary adenoma, growth hormone-secreting |
P63092
|
#601399 | Platelet disorder, familial, with associated myeloid malignancy |
Q01196
|
#610031 | Polymicrogyria, symmetric or asymmetric; pmgysa |
Q9BVA1
|
#103580 | Pseudohypoparathyroidism, type ia; php1a |
P63092
|
#603233 | Pseudohypoparathyroidism, type ib; php1b |
P63092
|
#612462 | Pseudohypoparathyroidism, type ic; php1c |
P63092
|
#607276 | Resting heart rate, variation in |
P08588
|
#275210 | Restrictive dermopathy, lethal |
P02545
|
#608971 | Severe combined immunodeficiency, autosomal recessive, t cell-negative, b cell-positive, nk cell-positive |
P08575
|
#609620 | Short qt syndrome 1; sqt1 |
Q12809
|
#601800 | Skin/hair/eye pigmentation, variation in, 3; shep3 |
P14679
|
#313200 | Spinal and bulbar muscular atrophy, x-linked 1; smax1 |
P10275
|
#183090 | Spinocerebellar ataxia 2; sca2 |
Q99700
|
#275355 | Squamous cell carcinoma, head and neck; hnscc |
P04637
|
#601104 | Supranuclear palsy, progressive, 1; psnp1 |
P10636
|
#188570 | Thyroid hormone resistance, generalized, autosomal dominant; grth |
P10828
|
#274300 | Thyroid hormone resistance, generalized, autosomal recessive; grth |
P10828
|
#145650 | Thyroid hormone resistance, selective pituitary; prth |
P10828
|
#103500 | Tietz syndrome |
O75030
|
#190300 | Tremor, hereditary essential, 1; etm1 |
P35462
|
#138900 | Uric acid concentration, serum, quantitative trait locus 1; uaqtl1 |
Q9UNQ0
|
#193510 | Waardenburg syndrome, type 2a; ws2a |
O75030
|
#610379 | West nile virus, susceptibility to |
P51681
|
#112100 | Yt blood group antigen |
P22303
|
KEGG | name | UniProt |
---|---|---|
H00033 | Adrenal carcinoma |
O00255
(related)
P04637 (related) |
H00034 | Carcinoid |
O00255
(related)
|
H00045 | Malignant islet cell carcinoma |
O00255
(related)
|
H00246 | Primary hyperparathyroidism |
O00255
(related)
|
H01102 | Pituitary adenomas |
O00255
(related)
|
H00038 | Malignant melanoma |
O75030
(related)
O75030 (marker) P04637 (related) P14679 (marker) |
H00169 | Ocular albinism |
O75030
(related)
|
H00759 | Waardenburg syndrome (WS) |
O75030
(related)
|
H01187 | Tietz syndrome |
O75030
(related)
|
H00016 | Oral cancer |
P00533
(related)
P00533 (marker) P04637 (related) P04637 (marker) P40763 (related) |
H00017 | Esophageal cancer |
P00533
(related)
P04637 (related) P04637 (marker) P35354 (related) |
H00018 | Gastric cancer |
P00533
(related)
P04626 (related) P04637 (related) |
H00022 | Bladder cancer |
P00533
(related)
P04626 (related) P04637 (related) |
H00028 | Choriocarcinoma |
P00533
(related)
P03956 (related) P04626 (related) P04637 (related) |
H00030 | Cervical cancer |
P00533
(related)
P04626 (related) |
H00042 | Glioma |
P00533
(related)
P00533 (marker) P04637 (related) P04637 (marker) |
H00055 | Laryngeal cancer |
P00533
(related)
P00533 (marker) P04637 (related) P04637 (marker) |
H00241 | Combined proximal and distal renal tubular acidosis (RTA type 3) |
P00918
(related)
|
H00436 | Osteopetrosis |
P00918
(related)
|
H00264 | Charcot-Marie-Tooth disease (CMT) |
P02545
(related)
|
H00294 | Dilated cardiomyopathy (DCM) |
P02545
(related)
|
H00420 | Familial partial lipodystrophy (FPL) |
P02545
(related)
|
H00563 | Emery-Dreifuss muscular dystrophy |
P02545
(related)
|
H00590 | Congenital muscular dystrophies (CMD/MDC) |
P02545
(related)
|
H00593 | Limb-girdle muscular dystrophy (LGMD) |
P02545
(related)
|
H00601 | Hutchinson-Gilford progeria syndrome |
P02545
(related)
|
H00663 | Restrictive dermopathy |
P02545
(related)
|
H00665 | Mandibuloacral dysplasia |
P02545
(related)
|
H01216 | Left ventricular noncompaction (LVNC) |
P02545
(related)
|
H00026 | Endometrial Cancer |
P03372
(marker)
P04626 (related) P04637 (related) Q92731 (marker) |
H00599 | 46,XX disorders of sex development (Disorders related to androgen excess) |
P04150
(related)
|
H00019 | Pancreatic cancer |
P04626
(related)
P04637 (related) P04637 (marker) |
H00027 | Ovarian cancer |
P04626
(related)
P04637 (related) |
H00031 | Breast cancer |
P04626
(related)
P04626 (marker) P04637 (related) |
H00046 | Cholangiocarcinoma |
P04626
(related)
P04637 (related) P35354 (related) |
H00004 | Chronic myeloid leukemia (CML) |
P04637
(related)
Q01196 (related) |
H00005 | Chronic lymphocytic leukemia (CLL) |
P04637
(related)
|
H00006 | Hairy-cell leukemia |
P04637
(related)
|
H00008 | Burkitt lymphoma |
P04637
(related)
|
H00009 | Adult T-cell leukemia |
P04637
(related)
|
H00010 | Multiple myeloma |
P04637
(related)
|
H00013 | Small cell lung cancer |
P04637
(related)
|
H00014 | Non-small cell lung cancer |
P04637
(related)
|
H00015 | Malignant pleural mesothelioma |
P04637
(related)
|
H00020 | Colorectal cancer |
P04637
(related)
P04637 (marker) |
H00025 | Penile cancer |
P04637
(related)
P04637 (marker) P14780 (related) P35354 (related) |
H00029 | Vulvar cancer |
P04637
(related)
|
H00032 | Thyroid cancer |
P04637
(related)
|
H00036 | Osteosarcoma |
P04637
(related)
P08684 (marker) |
H00039 | Basal cell carcinoma |
P04637
(related)
|
H00040 | Squamous cell carcinoma |
P04637
(related)
|
H00041 | Kaposi's sarcoma |
P04637
(related)
|
H00044 | Cancer of the anal canal |
P04637
(related)
|
H00047 | Gallbladder cancer |
P04637
(related)
|
H00048 | Hepatocellular carcinoma |
P04637
(related)
|
H00881 | Li-Fraumeni syndrome |
P04637
(related)
|
H01007 | Choroid plexus papilloma |
P04637
(related)
|
H00021 | Renal cell carcinoma |
P04637
(marker)
|
H00856 | Distal hereditary motor neuropathies (dHMN) |
P04792
(related)
|
H00093 | Combined immunodeficiencies (CIDs) |
P06239
(related)
|
H00079 | Asthma |
P07550
(related)
|
H00100 | Neutropenic disorders |
P08246
(related)
|
H00091 | T-B+Severe combined immunodeficiencies (SCIDs) |
P08575
(related)
|
H00069 | Glycogen storage diseases (GSD) |
P10253
(related)
|
H00024 | Prostate cancer |
P10275
(related)
|
H00062 | Spinal and bulbar muscular atrophy (SBMA) |
P10275
(related)
|
H00608 | 46,XY disorders of sex development (Disorders in androgen synthesis or action) |
P10275
(related)
|
H00609 | 46,XY disorders of sex development (Other) |
P10275
(related)
|
H00058 | Amyotrophic lateral sclerosis (ALS) |
P10636
(related)
Q13148 (related) |
H00077 | Progressive supranuclear palsy (PSP) |
P10636
(related)
|
H00078 | Frontotemporal lobar degeneration (FTLD) |
P10636
(related)
|
H00249 | Thyroid hormone resistance syndrome |
P10828
(related)
|
H01205 | Coumarin resistance |
P11712
(related)
|
H00168 | Oculocutaneous albinism (OCA) |
P14679
(related)
|
H00479 | Metaphyseal dysplasias |
P14780
(related)
|
H00457 | Primary hypertrophic osteoarthropathy (PHO) |
P15428
(related)
|
H01246 | Isolated congenital nail clubbing (ICNC) |
P15428
(related)
|
H00250 | Congenital nongoitrous hypothyroidism (CHNG) |
P16473
(related)
|
H01269 | Congenital hyperthyroidism |
P16473
(related)
|
H00548 | Brunner syndrome |
P21397
(related)
|
H00208 | Hyperbilirubinemia |
P22309
(related)
|
H01031 | Orthostatic intolerance (OI) |
P23975
(related)
|
H00490 | Diaphyseal dysplasia with anemia (Ghosal) |
P24557
(related)
|
H01171 | Poor drug metabolism (PM) |
P33261
(related)
|
H00107 | Other well-defined immunodeficiency syndromes |
P40763
(related)
|
H00059 | Huntington's disease (HD) |
P42858
(related)
|
H00480 | Non-syndromic X-linked mental retardation |
P50052
(related)
Q99714 (related) |
H00244 | Pseudohypoparathyroidism |
P63092
(related)
|
H00441 | Progressive osseous heteroplasia (POH) |
P63092
(related)
|
H00501 | Fibrous dysplasia, polyostotic |
P63092
(related)
|
H00001 | Acute lymphoblastic leukemia (ALL) (precursor B lymphoblastic leukemia) |
Q01196
(related)
Q01196 (marker) Q03164 (related) Q03164 (marker) |
H00003 | Acute myeloid leukemia (AML) |
Q01196
(related)
Q01196 (marker) Q13951 (marker) |
H00978 | Thrombocytopenia (THC) |
Q01196
(related)
|
H00002 | Acute lymphoblastic leukemia (ALL) (precursor T lymphoblastic leukemia) |
Q03164
(related)
|
H00720 | Long QT syndrome |
Q12809
(related)
|
H00725 | Short QT syndrome |
Q12809
(related)
|
H00838 | Congenital fibrosis of the extraocular muscles (CFEOM) |
Q13509
(related)
|
H00612 | Primary open angle glaucoma |
Q16678
(related)
|
H01075 | Peters anomaly |
Q16678
(related)
|
H01159 | Anterior segment dysgenesis (ASD) |
Q16678
(related)
|
H01203 | Primary congenital glaucoma (PCG) |
Q16678
(related)
|
H00268 | Lissencephaly (LIS) |
Q71U36
(related)
|
H00063 | Spinocerebellar ataxia (SCA) |
Q99700
(related)
|
H00658 | Syndromic X-linked mental retardation |
Q99714
(related)
|
H00925 | 2-Methyl-3-hydroxybutyryl-CoA dehydrogenase (MHBD) deficiency |
Q99714
(related)
|
MESH or OMIM | name |
KNApSAcK
metabolite |
---|---|---|
D003877 | Dermatitis, Contact |
C00000805
C00000619 |
D010146 | Pain |
C00000156
C00000619 |
D007249 | Inflammation |
C00004712
C00000619 |
D056486 | Drug-Induced Liver Injury |
C00004712
C00000619 |
D006331 | Heart Diseases |
C00000619
|
D047508 | Massive Hepatic Necrosis |
C00003359
|
D010195 | Pancreatitis |
C00003359
|
D020258 | Neurotoxicity Syndromes |
C00029423
|
D017495 | Hyperpigmentation |
C00017521
|
D001008 | Anxiety Disorders |
C00000356
|
D008288 | Malaria |
C00003359
|
D004487 | Edema |
C00004712
|
D006099 | Granuloma |
C00004712
|
D007022 | Hypotension |
C00004712
|
D007898 | Leishmaniasis, Visceral |
C00003359
|
D003866 | Depressive Disorder |
C00000156
|
D002177 | Candidiasis |
C00017523
|
D001943 | Breast Neoplasms |
C00000619
|
D017449 | Dermatitis, Allergic Contact |
C00000619
|
D003875 | Drug Eruptions |
C00000619
|
D016780 | Malaria, Vivax |
C00003359
|
D006461 | Hemolysis |
C00000619
|
D006930 | Hyperalgesia |
C00000619
|
D006967 | Hypersensitivity |
C00000619
|
D008545 | Melanoma |
C00000619
|
D009361 | Neoplasm Invasiveness |
C00000619
|
D009362 | Neoplasm Metastasis |
C00000619
|
D009374 | Neoplasms, Experimental |
C00000619
|
D009389 | Neovascularization, Pathologic |
C00000619
|
D009410 | Nerve Degeneration |
C00000619
|
D010149 | Pain, Postoperative |
C00000619
|
D010300 | Parkinson Disease |
C00000619
|
D011833 | Radiation Injuries, Experimental |
C00000619
|
D012481 | Salmonella Infections, Animal |
C00000619
|
D012878 | Skin Neoplasms |
C00000619
|
D013035 | Spasm |
C00000619
|
D013203 | Staphylococcal Infections |
C00000619
|
D013274 | Stomach Neoplasms |
C00000619
|
D013276 | Stomach Ulcer |
C00000619
|
D014581 | Urticaria |
C00000619
|
D002583 | Uterine Cervical Neoplasms |
C00000619
|